REVENUES

9 Months Ended

Sep. 30, 2018

Income Statement [Abstract]

REVENUES

NOTE 5 – REVENUES (AS RESTATED)

The following table summarizes the Company’s disaggregation of revenues:

	Nine Months Ended September 30,
(U.S. dollars in thousands)	2018		2017
Pfizer	$	4,649	$	10,198
Brazil	$	2,573	$	6,575
Total revenues from selling goods	$	7,222	$	16,773
Revenues from license and R&D services	$	16,665